Kawasaki Syndrome: A Special View To New Entities Like MIS-C, PIMS and Kawasaki-Like Features In Covid-19 Disease With Recommendation of Classification

2021 ◽  
Author(s):  
Stefan Bittmann
Keyword(s):  
Lymph Node ◽  
Systemic Inflammation ◽  
Kawasaki Syndrome ◽  
Necrotizing Vasculitis ◽  
Mucocutaneous Lymph Node Syndrome ◽  
Infectious Origin ◽  
Lymph Node Syndrome

Kawasaki syndrome or mucocutaneous lymph node syndrome (MCLS) is an acute, febrile, systemic illness characterized by inflammation (necrotizing vasculitis) of the small and medium-sized arteries. In addition, systemic inflammation is present in many organs. The cause is unknown; an infectious origin is suspected, favored by a hereditary basis.

scholarly journals Coronary Artery Aneurysms Due to Kawasaki Disease – a Rare Cause of Acute Myocardial Infarction

2019 ◽  
Vol 4 (4) ◽  
pp. 190-192
Author(s):  
Ioana Cîrneală ◽  
Dan Păsăroiu ◽  
István Kovács ◽  
Imre Benedek ◽  
Rodica Togănel
Keyword(s):  
Myocardial Infarction ◽  
Acute Myocardial Infarction ◽  
Lymph Node ◽  
Kawasaki Disease ◽  
Kawasaki Syndrome ◽  
Mucocutaneous Lymph Node Syndrome ◽  
Coronary Artery Aneurysms ◽  
St Elevation ◽  
Infectious Etiology ◽  
Lymph Node Syndrome

Abstract Kawasaki disease, also known as Kawasaki syndrome or mucocutaneous lymph node syndrome, is a pathology that causes inflammation in the walls of medium sized arteries causing symptoms such as fever, lymphadenopathy, rash, and erythema of eyes, lips, nose, palms and feet. The cause is unknown, although clinical features strongly suggest an infectious etiology. We present the case of a 53-year-old woman, known with Kawasaki disease since childhood, with different associated pathologies, that presented with acute inferior ST elevation myocardial infarction.

Kawasaki Syndrome (Mucocutaneous Lymph Node Syndrome)

1980 ◽  
Vol 2 (4) ◽  
pp. 107-114
Author(s):  
Marian E. Melish
Keyword(s):  
United States ◽  
Lymph Node ◽  
Clinical Course ◽  
Medical Center ◽  
The United States ◽  
Kawasaki Syndrome ◽  
Mucocutaneous Lymph Node Syndrome ◽  
Research Committee ◽  
Children First ◽  
Lymph Node Syndrome

Kawasaki syndrome or the mucocutaneous lymph node syndrome (MCLS, MLNS) is an acute febrile exanthematous illness of children, first recognized in Japan by Kawasaki in 1967.1 In 1970, the Research Committee of MCLS, supported by the Ministry of Health and Welfare of the Japanese government, organized a case registry to elucidate the clinical, pathologic, epidemiologic, and etiologic features. By 1974, the committee had collected approximately 5,000 cases from all over Japan.1,2 The illness has continued to be recognized in Japan with more than 10,000 cases registered by 1979. The disease was recognized independently in the United States by Melish et al with 12 cases encountered between 1971 and 1974.3,4 Although these American workers had no knowledge of the Japanese experience they independently identified the same diagnostic criteria. Later consultations with Japanese MCLS researchers have established that the cases in Hawaii and the cases in Japan were indistinguishable in their presenting manifestations and their clinical course. Since 1974, Kawasaki syndrome has been recognized worldwide. Outside Japan, the illness appears to be most prevalent in Hawaii which has the largest published series3; the largest proportion of cases in the United States reported to the Center for Disease Control come from this state. The experience at the Kapiolani-Children's Medical Center now includes more than 100 cases from various parts of Hawaii.

Studies on Aspirin Administration in Acute Febrile Mucocutaneous Lymph Node Syndrome (MCLS), Based on the Antithrombotic Effects of Aspirin

1979 ◽  
Vol 21 (1) ◽  
pp. 55-55 ◽  
Author(s):  
Akira Shirahata ◽  
Kaneo Yamada ◽  
Toshio Nojiri ◽  
Yoshikazu Miyaji ◽  
Yukio Iwasaki ◽  
...  
Keyword(s):  
Lymph Node ◽  
Mucocutaneous Lymph Node Syndrome ◽  
Antithrombotic Effects ◽  
Lymph Node Syndrome
Sign in / Sign up

Export Citation Format

Share Document